Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
News provided by
Aug 25, 2025, 10:00 ET
The new company will focus on the development of novel, targeted cancer therapeutics.
GAITHERSBURG, Md.
Aug. 25, 2025
March 2026“We are exploring a new direction with this strategic decision,” said Dr. Ahmed Kilani, President and Laboratory Director of Clongen Laboratories, LLC. “Our intention is to continue serving our clients while establishing Clongen Pharma, LLC as a separate entity to complement our current services and meet additional market needs. This initiative aligns with our objectives to address health challenges,” added Dr. Kilani.
Clongen Laboratories is a global leader in molecular diagnostics for infections diseases, contract research services and pre-clinical trial support. With an diverse pathogen detection menu of more than 250 infectious agents, an active CLIA certification since 2004, a recent CAP accreditation and clinical laboratory licenses in five states, Clongen Laboratories is positioned to meet market needs in molecular diagnostics and research support services.
Clongen Pharma, LLC will be headquartered in Gaithersburg, MD, focusing on developing and evaluating technologies for the treatment of blood cancers and solid tumors.
The company will recruit scientists with relevant expertise in cancer biology and therapeutic approaches. Further details, including the launch of the company website, will be provided in future updates.
“We anticipate engaging with academic institutions and establishing avenues for potential partnerships and investments,” said Dr. Ahmed Kilani.
About Clongen Pharma, LLC
Clongen Pharma, LLC is a privately held early-stage cancer therapeutics company located in Gaithersburg, Maryland. Additional information will be announced in upcoming months.
About Clongen Laboratories, LLC
Clongen Laboratories provides contract research services and molecular diagnostics as a CAP-accredited facility, licensed as a clinical laboratory in four states. Since its founding in 2004, the company has expanded its service offerings. Based in Gaithersburg, MD, Clongen Laboratories is positioned near major research and biotechnology institutions. The laboratory develops diagnostic tests using rapid detection methods for human and animal health. For more information, please visit www.clongen.com
Contact:
Dr. Ahmed Kilani, President and Laboratory Director: 301-916-0173 x201
Elena Ralchenko, Office Manager: 301-916-0173 x200
E-mail: elena@clongen.com
SOURCE Clongen Laboratories, LLC
For complete press release, please visit: Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
GAITHERSBURG, Md., Sept. 24, 2024 /PRNewswire/ — Clongen Laboratories, LLC, a leading provider of Contract Research Services and Infectious Disease Diagnostic Services, celebrates 20 years of service. The company was founded by Dr. Ahmed Kilani and launched its first laboratory operation in Germantown, MD in 2004.
“Since our journey began in 2004, Clongen Labs has grown significantly and established a reputation of quality in all areas of services the laboratory offers. This is an exciting time in our organization’s lifecycle and we are excited to continue onto our next phase of growth, Kilani said.” “As we expand our offerings in contract research services and infectious disease diagnostic tests, we push the boundaries of science and remain focused on our mission which is improving human and animal health. We are grateful to our clients and partners for their trust and support, which has enabled us to reach this substantial milestone, Kilani added”.
In an age of technological revolution, Clongen Labs is uniquely positioned to excel and utilize innovative science to serve our broad base of clients. With many years of extensive expertise and seasoned talent in molecular biology, cell biology and microbiology, Clongen Laboratories is an invaluable resource for organizations that require professional scientific support to test or release their products.
“This anniversary is a significant milestone and reflects our enduring commitment to advancing scientific research, Kilani stated.”
Since its inception, Clongen Labs served as a CLIA-certified/CAP accredited clinical reference laboratory focused on infectious disease diagnostics and a Contract Research Organization (CRO) that offered lot release tests such as Sterility, Endotoxin, Mycoplasma and Adventitious virus detection assays among many other services. Our infectious disease testing division offers more than 240 molecular tests covering viruses, bacteria, yeast, mold and parasites that can cause human disease. For more information about Clongen’ s menu offerings, please visit: www.clongen.com
About Clongen Laboratories
A leader in Contract Research Services and Molecular Diagnostics, Clongen Laboratories, a CAP-accredited facility, is licensed as a clinical laboratory in four states. Since its inception in 2004, the company has enjoyed rapid growth and steadily expanded its menu offerings. Located in Gaithersburg, on the I-270 corridor in Montgomery County, MD, Clongen enjoys a strategic presence in close proximity to the National Institutes of Health, Johns Hopkins University, The University of Maryland and other biotechnology institutions. Clongen Laboratories is a pioneer in developing innovative diagnostic tests utilizing rapid detection methods with the goal of improving human and animal health. For more information, please visit www.clongen.com
Contact:
Dr. Ahmed Kilani, President and Laboratory Director: 301-916-0173 x213
Elena Ralchenko, Office Manager: 301-916-0173 x200
E-mail: elena@clongen.com
SOURCE Clongen Laboratories, LLC
A link to the full release is shown below:
Clongen Laboratories Celebrates 20th Anniversary (prnewswire.com)
October 27,2023
We invite you to visit our Contract Research Division website. The splash screen will show by clicking the company logo on the top left corner, and you can visit our Contract Research Division website. We offer an extensive menu of custom and lot release assays in compliance with the United States Pharmacopeia procedures and FDA regulations. Feel free to call Dr. Ahmed Kilani if you have any questions.
October 23, 2023
A New Approach to Overcome Low Detection Limits. Over millions of years, tick-borne pathogens have adapted to the host in a way that ensures their survival. They evolved and developed strategies to evade and down-regulate the immune response and hide in tissues to avoid being attacked by immune cells, antibodies, complement, and other immune reactive elements. The evolution of those stealth pathogens introduced many challenges to laboratories trying to diagnose infections with tick-borne pathogens.
The copy numbers can be extremely low in whole blood and tissues. Our strategy is to amplify the target before trying to detect a signal. We offer an enrichment protocol that allows those fastidious organisms to propagate to larger numbers over a 10-day incubation period, making it easier for laboratory scientists to detect them using state-of-the-art Time Polymerase Chain Reaction detection platforms.
Please call our main Laboratory Number to request an enrichment medium Collection kit. (877-CLONGEN (256-6436)
02/15/2012
Clongen Labs received a formal registration from the Department of Health and Human Services as a Blood and other related product processing facility. Since the inception of the company’s Germantown, MD location, we have been operating in compliance with Good Laboratory Practices (GLP) and by FDA guidelines. All licenses and certifications are listed with a copy of each license under “About Us”/”Licenses and Certifications”.
04/04/20213
We are pleased to announce that Clongen Laboratories received a Clinical Laboratory License from the State of Rhode Island Department of Health on 4/4/2013. We look forward to serving the residents of Rhode Island and assisting them with Laboratory testing.
For questions, please get in touch with Elena Ralchenko at 877-CLONGEN (256-6436)
04/10/2013
Clongen Labs received an out-of-state Clinical Laboratory License from the Pennsylvania Department of Health on 4/10/2013.
We look forward to working with Health Care Professionals and patients from Pennsylvania.
Clongen Laboratories, LLC is moving to a new location
Jul 16, 2013, 11:06 ET
GAITHERSBURG, Md., July, 16, 2013 /PRNewswire/ — Clongen Laboratories, LLC is moving to a new location on August 10, 2013. “We are expanding our business. We ultimately made the decision to move to accommodate the quickly increasing demand for our clinical diagnostics and contract research services,” said Dr. Ahmed Kilani, President of Clongen Laboratories, LLC.
The new facility is located at 211 Perry Parkway, Suite 6 in Gaithersburg, Maryland. Found at the heart of the biotechnology corridor, the new location is in close proximity to other laboratories in the scientific community, including the National Institutes of Health, and Johns Hopkins University. The new space measures 6000 square feet, doubling the size of the current location. “We custom-built the lab and equipped it with state-of-the-art technology to provide our clients with the highest level of service,” he continued.
The phone and fax lines will remain unchanged and there will be no interruption in service.
Clongen Laboratories, LLC will host a grand opening ceremony on September 2, 2013 and an open house on September 18, 2013 from 8 AM to 5 PM. “We cordially invite all our current clients, prospective clients, physicians, patients, and friends to tour our new facility,” said Shukria Mirzaee, office manager.
About Clongen Laboratories, LLC: Since its opening in 2004, Clongen Laboratories, LLC obtained CLIA and FDA certifications, and holds clinical licenses in five states. It offers more than 250 DNA and RNA detection based tests for infectious diseases. Clongen Laboratories, LLC specializes in testing ticks, blood, and human tissues for Lyme disease and other tick-borne illnesses. It also provides lot release testing services and custom assays for research organizations.
For more information on Clongen Laboratories, LLC, please visit our website at http://www.clongen.com or e-mail us at cs@clongen.com
For Customer Support, please contact:
Elena Ralchenko, Office Manager – 301-916-0173, Ext 200
Anna Ralchenko, Media Contact – 301-916-0173, Ext 202
Dr. Ahmed Kilani
211 Perry Parkway, Suite 6
Gaithersburg, MD 20877
Phone: 301-916-0173
Fax: 301-916-0175
Email: cs@clongen.com
SOURCE Clongen Laboratories, LLC
GAITHERSBURG, Md., Dec. 4, 2014 /PRNewswire-USNewswire/ — Clongen Laboratories, LLC invites visitors to explore its new website and expanded test list. The new website is designed to be user-friendly, allowing customers to easily access the lists of clinical diagnostic services and contract research services provided.
Clongen announced eight new test offerings in August, 2014 to detect and identify emerging pathogens implicated in severe to fatal cases resulting from tick and other arthropod bites. “Clongen is now making over 100 additional real-time PCR-based diagnostic assays available by the end of the year, falling under the categories of urological and gynecological infections, respiratory pathogens, gastrointestinal pathogens, and dermatologic and soft tissue infections,” Dr. Ahmed Kilani said.
Clongen’s new website will provide straightforward navigation through the tests lists and access to updated clinical order forms. There will be ongoing additions to the website, including more links from the test menu to facts about each organism, plus credible and easy to follow journal articles. Users are urged to monitor the new site for exciting additions in the upcoming months.
“The overall focus of our laboratory remains unchanged since the company’s inception in 1999,” Kilani says. “While our focus is improving human health through the utilization of cutting edge technologies to provide the most accurate diagnostic assays, we strive to develop new tests for esoteric conditions that affect very small numbers of individuals as well as other infectious agents that have a broader patient population base.”
To view the new website and complete test menu, visit www.clongen.com
About Clongen Laboratories
A leader in molecular diagnostics, Clongen Laboratories is licensed in five states and holds two active FDA registrations. Since its inception in 2004, the company has enjoyed rapid growth and steadily expanded its menu offerings. Located in Gaithersburg, on the I-270 corridor in Montgomery County, MD, Clongen enjoys a strategic presence in close proximity to the National Institutes of Health, Johns Hopkins University, The University of Maryland, and other biotechnology institutions. Clongen Laboratories is a pioneer in developing innovative diagnostic tests utilizing rapid detection methods with the goal of improving human health. For more information, please visit www.clongen.com
Contact:
Dr. Ahmed Kilani, President and Laboratory Director: 301-916-0173 x213
Elena Ralchenko, Office Manager: 301-916-0173 x200
E-mail: cs@clongen.com
SOURCE Clongen Laboratories
GAITHERSBURG, Md., Oct. 24, 2017 /PRNewswire-USNewswire/ — Clongen Laboratories, LLC announced that the clinical laboratory received accreditation from the College of American Pathologists (CAP). The CAP accreditation is a globally recognized program designed to maintain the highest standards of excellence in laboratory practices and is awarded to facilities that meet these benchmarks of quality in clinical laboratory testing services.
GAITHERSBURG, Md., May 11, 2016 /PRNewswire-USNewswire/ — With the most recent outbreak of Zika virus and confirmed cases in the Americas, the need for diagnosis can not be overemphasized. The WHO estimates that 3 to 4 million people will contract Zika virus worldwide in the next 12 months and has declared Zika virus infection as a Public Health Emergency of International Concern (PHEIC). Though no locally transmitted cases have been reported within the United States as of yet, currently close to 500 cases of travel-associated cases have already been reported. Like Dengue and Chikungunya viruses, Zika virus is transmitted primarily through the bite of an infected Aedes species mosquito. Disease has also recently been confirmed to be transmitted through sexual contact. Urgency to diagnose Zika virus is greatest in pregnant women and women of child-bearing age that are planning to start a family and have travelled to or have a partner who has travelled to areas where Zika virus is known to exist. Microcephaly in newborns born to mothers who were infected with Zika virus while pregnant has been confirmed in 9 countries. Since 2007, Zika virus infections have been reported in 61 countries and territories according to the CDC.
GAITHERSBURG, Md., March 4, 2015 /PRNewswire-USNewswire/ — Clongen Laboratories, LLC
We are pleased to announce the addition of a veterinary diagnostic services division at Clongen Laboratories.
Dr. Erica Fratz has spent several months developing the veterinary testing menu, which offers over 100 new assays to identify diseases in animals. “As the human population continues to grow, so do the interactions among humans, domesticated animals, and wild animals. Wild animal populations are the primary reservoir for emerging diseases, and as we, and our domesticated animals, occupy more of this planet, we introduce new relationships among wild animals, domestic animals, and people,” commented Dr. Fratz, a Senior Scientist. “Offering veterinary testing has been in the plans for Clongen for several years, and now we are making it happen,” Dr. Kilani, President and Laboratory Director stated.
GAITHERSBURG, Md., Dec. 4, 2014 /PRNewswire-USNewswire/ — Clongen Laboratories, LLC invites visitors to explore its new website and expanded test list. The new website is designed to be user-friendly, allowing customers to easily access the lists of clinical diagnostic services and contract research services provided.
Clongen announced eight new test offerings in August, 2014 to detect and identify emerging pathogens implicated in severe to fatal cases resulting from tick and other arthropod bites. “Clongen is now making over 100 additional real-time PCR-based diagnostic assays available by the end of the year, falling under the categories of urological and gynecological infections, respiratory pathogens, gastrointestinal pathogens, and dermatologic and soft tissue infections,” Dr. Ahmed Kilani said.
GAITHERSBURG, Md., Aug. 26, 2014 /PRNewswire — Clongen Laboratories, celebrating its tenth anniversary, is a leading provider of diagnostic and contract research services. The company announced new test offerings to detect and identify emerging pathogens most recently implicated in severe to fatal cases resulting from tick and other arthropod bites.
Since 2004, Clongen Laboratories has provided a comprehensive menu of test services. Clongen’s newest test offerings will enable clinicians to offer early treatment, often averting more serious symptoms in patients newly diagnosed with tick or other arthropod-borne illnesses.
GERMANTOWN, Md., Nov. 15, 2011 /PRNewswire/ — Since its inception in 1999, Clongen Laboratories, a CLIA licensed facility with a Maryland Clinical Laboratory license, has focused on improving human health by refining diagnostic tests for infectious diseases and providing contract research services for pharmaceutical, biotechnology, government, and academic institutions.